Table 1.
Univariate and multivariate COX analysis.
Characteristics | Total (N) | Univariate analysis |
Multivariate analysis |
||
---|---|---|---|---|---|
Hazard ratio (95% CI) | p Value | Hazard ratio (95% CI) | p Value | ||
T stage | 241 | ||||
T1 | 138 | Reference | |||
T2 | 72 | 1.109 (0.477–2.578) | 0.810 | 0.000 (0.000-Inf) | 0.999 |
T4 | 10 | 10.411 (4.231–25.618) | <0.001 | ||
T3 | 21 | 3.251 (1.274–8.292) | 0.014 | 2.470 (0.268–22.747) | 0.425 |
N stage | 193 | ||||
N0 | 133 | Reference | |||
N1 | 60 | 3.544 (1.572–7.987) | 0.002 | 3.319 (0.967–11.398) | 0.057 |
M stage | 125 | ||||
M0 | 114 | Reference | |||
M1 | 11 | 4.290 (1.401–13.137) | 0.011 | 0.025 (0.000-Inf) | 1.000 |
Clinical stage | 295 | ||||
Stage I | 158 | Reference | |||
Stage II | 69 | 0.895 (0.417–1.921) | 0.776 | 0.000 (0.000-Inf) | 0.999 |
Stage III | 46 | 1.570 (0.732–3.366) | 0.247 | 0.000 (0.000-Inf) | 0.999 |
Stage IV | 22 | 5.109 (2.559–10.199) | <0.001 | ||
Age | 302 | ||||
< =50 | 186 | Reference | |||
>50 | 116 | 1.295 (0.761–2.204) | 0.340 | ||
Histological type | 302 | ||||
Adenosquamous | 52 | Reference | |||
Squamous cell carcinoma | 250 | 0.983 (0.481–2.011) | 0.963 |